Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD2066 in Painful Diabetic Neuropathy
NCT00857623Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD-2066 in diabetic neuropathy, sponsored by AstraZeneca. Started Feb 2009; status: completed.
02
Drugs
AZD-2066
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT00857623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00857623.